India Launches Once-Weekly Basal Insulin

On 9th July 2026, Danish drugmaker Novo Nordisk launched Awiqli (insulin icodec), the world's first once-weekly basal insulin for adults with Type 1 and Type 2 diabetes.

  • The ONWARDS-1 clinical programme showed better HbA1c reduction and improved Time in Range compared to daily insulin glargine U100.
  • The simplified weekly dosing is expected to improve treatment adherence and reduce psychological barriers to insulin therapy.
  • The treatment is approved for adults with Type 1 and Type 2 diabetes requiring basal insulin therapy.
  • India has over 101 million people with diabetes and around 136 million people with ....
Do You Want to Read More?
Subscribe Now
To get access to detailed content

Already a Member? Login here

Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material since 2018 of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Be an Annual Subscriber

Science & Technology